Acute myeloid leukemia
Showing 26 - 50 of >10,000
Acute Myeloid Leukemia, Adult Trial in Hangzhou (cladribine + homoharringtonine + cytarabine)
Recruiting
- Acute Myeloid Leukemia, Adult
- cladribine + homoharringtonine + cytarabine
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, Zhejiang University School of Med
Jun 13, 2023
Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse Trial in Miami (Bomedemstat,
Recruiting
- Acute Myeloid Leukemia
- +2 more
-
Miami, FloridaUniversity of Miami
Dec 22, 2022
Refractory/Relapse Acute Myeloid Leukemia Trial in Kunming (Venetoclax)
Recruiting
- Refractory/Relapse Acute Myeloid Leukemia
-
Kunming, Yunnan, ChinaDepartment of Hematology,920th Hospital of Joint Logistic Suppor
Mar 28, 2023
Relapsed/Refractory Acute Myeloid Leukemia Trial in Hangzhou (B7-H3 target, CAR gene modified gdT cell injection)
Recruiting
- Relapsed/Refractory Acute Myeloid Leukemia
- B7-H3 target, CAR gene modified gdT cell injection
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital, Zhejiang University School of Med
Feb 15, 2023
Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in
Not yet recruiting
- Acute Myeloid Leukemia
- (no location specified)
Sep 22, 2023
Acute Myeloid Leukemia Trial in Fuzhou (CLL1/+CD33 CAR-T)
Not yet recruiting
- Acute Myeloid Leukemia
- CLL1/+CD33 CAR-T
-
Fuzhou, Fujian, ChinaFujian Provincial Children's Hospital
Jul 10, 2023
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Houston (Decitabine, Quizartinib,
Recruiting
- Acute Myeloid Leukemia
- +4 more
- Decitabine
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 27, 2023
Venetoclax Plasma Concentration and Remission in Acute Myeloid
Not yet recruiting
- Adult Acute Myeloid Leukemia
- Blood sampling for venetoclax drug dosage (venous puncture)
- (no location specified)
Sep 13, 2023
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute
Active, not recruiting
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- +2 more
- 8-Chloroadenosine
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 4, 2023
Acute Myeloid Leukemia Trial in Suzhou (Venetoclax, Homoharringtonine, Cytarabine)
Recruiting
- Acute Myeloid Leukemia
- Venetoclax
- +2 more
-
Suzhou, Jiangsu, ChinaQiu Huiying
Mar 28, 2023
GilteRInf 2022 Study (Gilteritinib Related Infections)
Active, not recruiting
- Acute Myeloid Leukemia
-
Roma, RM, ItalyMaria Ilaria Del Principe
Mar 17, 2023
Acute Myeloid Leukemia Trial in Cincinnati (CIML-NK Cells)
Recruiting
- Acute Myeloid Leukemia
- CIML-NK Cells
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Jan 4, 2023
Relapsed or Refractory Acute Myeloid Leukemia Trial in Taiyuan (Selinexor, Homoharringtonine, Daunorubicin)
Recruiting
- Relapsed or Refractory Acute Myeloid Leukemia
- Selinexor
- +5 more
-
Taiyuan, Shanxi, ChinaTao Wang
Feb 9, 2023
AML Trial in Guanzhou (CLAG)
Not yet recruiting
- AML
- CLAG
-
Guanzhou, Guangdong, China
- +1 more
May 16, 2023
Allogeneic Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Suzhou
Recruiting
- Allogeneic Hematopoietic Stem Cell Transplantation
- +2 more
- VEN+AZA+Modified BUCY
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Apr 10, 2023
Acute Myeloid Leukemia Trial in Memphis (Venetoclax, Azacitidine, Cytarabine)
Not yet recruiting
- Acute Myeloid Leukemia
- Venetoclax
- +9 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jul 21, 2023
Acute Myeloid Leukemia Trial in Beijing (azacytidine;cytarabine;aclamycin;Chidamide;venetoclax;granulocyte)
Recruiting
- Acute Myeloid Leukemia
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Dec 13, 2022
Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Recruiting
- Acute Bilineal Leukemia
- +8 more
- Azacitidine
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jan 24, 2023
Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2 Trial in Boston (BXCL701)
Not yet recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome With Excess Blasts-2
-
Boston, MassachusettsDana Farber Cancer Institute
Jan 26, 2023
Acute Myeloid Leukemia Trial (NK cells, Talazoparib 1 MG [Talzenna])
Not yet recruiting
- Acute Myeloid Leukemia
- NK cells
- Talazoparib 1 MG [Talzenna]
- (no location specified)
Jan 9, 2023
Acute Myeloid Leukemia, Recurrent Adult Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Anti-CD33 CAR
Not yet recruiting
- Acute Myeloid Leukemia
- +3 more
- Anti-CD33 CAR T-cells
- Lymphodepletion Therapy
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 3, 2023
Acute Myeloid Leukemia Trial in Houston (Azacitidine, Venetoclax, NK Cells)
Not yet recruiting
- Acute Myeloid Leukemia
- Azacitidine
- +2 more
-
Houston, TexasM.D. Anderson Cancer Center
Apr 17, 2023
Acute Myeloid Leukemia Trial in Valencia (AFM28)
Recruiting
- Acute Myeloid Leukemia
-
Valencia, SpainHospital Universitari i Politècnic La Fe
Apr 5, 2023
Acute Myeloid Leukemia Trial in United States (Standard Leukemia Care, Palliative Care)
Active, not recruiting
- Acute Myeloid Leukemia
- Standard Leukemia Care
- Palliative Care
-
Boston, Massachusetts
- +3 more
Jan 24, 2023
Acute Myeloid Leukemia Trial in Kunming (CLL1 and CD38 dual-target CAR-T injection)
Recruiting
- Acute Myeloid Leukemia
- CLL1 and CD38 dual-target CAR-T injection
-
Kunming, Yunnan, China920th Hospital of Joint LogisticsSupport Force of People's Liber
Oct 26, 2023